In 1978, Cipla started manufacturing of Metered-Dose Inhaler (MDI). 1984 was the year when the company name was changed from The Chemical, Industrial & Pharmaceutical Laboratories to Cipla Limited.

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be overlooked.

Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 ...

Amid high AQI in Delhi, there's been a surge in the demand for respiratory drugs. Foracort, a respiratory drug, has emerged ...

Apart from the above, the company also develops medicines to treat a few other conditions. With a market capitalization exceeding Rs.517 billion (7.9 billion USD), Cipla is reported to be one of the ...

Cipla Ltd, a major player in the Indian pharmaceutical sector, currently trades at ₹1,418. This price reflects a decrease of 4.04% at 11:26 a.m. on October 30. Over the past year, Cipla's stock ...

Cipla's consolidated revenue from operations stood at ₹7,051.02 crores during the quarter ended September from ₹6,678.15 crore in Q2FY24, a year-on-year jump of nearly 10.5%. The firm ...

Shares of pharmaceutical major Cipla dropped over 4 per cent on Wednesday at Rs 1,417 per share after analysts highlighted near-term challenges following a muted performance in the second quarter ...

Cipla Ltd.'s consolidated net profit rose 13% in the second quarter of the current financial year, meeting analysts' estimates. The drugmaker posted a profit of Rs 1,305.01 crore in the quarter-ended ...